Autonomous University of Barcelona Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2008
NCT00755027
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Jose Antonio Hernández-Hermoso, PhD | Neurology Service at Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona (Barcelona, Spain) | Universitat Autonoma de Barcelona (UAB)

Active Ingredients

Drugs in Phase 4 Trials (1)

rasagiline (azilect) (1 trial)

Drugs in Other Trials (1)

platelet rich plasma (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Parkinson Disease (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2